The Convergent procedure’s primary goal is to restore normal sinus rhythm to the heart. This procedure is called "hybrid" because it involves a collaboration between a cardiac electrophysiologist and a cardiac surgeon. Led by Professor Weerasooriya, the team carefully selects patients who would benefit from the Convergent procedure.

The Convergent procedure is typically recommended for patients with persistent AF or those who have previously failed ablation procedures. These patients generally have AF sources separate or distant from the pulmonary veins, and represent the more challenging end of the AF spectrum. However, not all AF patients are suitable for the Convergent procedure.

The procedure involves two stages: the first stage is a minimally invasive surgical ablation targeting the posterior left atrial wall, performed by the cardiac surgeon, and the second stage is a mapping and consolidation catheter ablation performed by the cardiac electrophysiologist. The aim of the procedure is to ablate areas of the heart that are causing atrial fibrillation (AF). 

The Convergent procedure has a well-established track record, with over 9,000 procedures performed in the US and Europe to date.

For more information about the Convergent procedure download out information booklet here.